242 related articles for article (PubMed ID: 27267252)
1. N-Myristoyltransferase Inhibition Induces ER-Stress, Cell Cycle Arrest, and Apoptosis in Cancer Cells.
Thinon E; Morales-Sanfrutos J; Mann DJ; Tate EW
ACS Chem Biol; 2016 Aug; 11(8):2165-76. PubMed ID: 27267252
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein N-myristoylation: a therapeutic protocol in developing anticancer agents.
Das U; Kumar S; Dimmock JR; Sharma RK
Curr Cancer Drug Targets; 2012 Jul; 12(6):667-92. PubMed ID: 22463587
[TBL] [Abstract][Full Text] [Related]
3. N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase.
Lodge JK; Jackson-Machelski E; Devadas B; Zupec ME; Getman DP; Kishore N; Freeman SK; McWherter CA; Sikorski JA; Gordon JI
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():357-366. PubMed ID: 9043113
[TBL] [Abstract][Full Text] [Related]
4. Whole Proteome Profiling of
Goya Grocin A; Serwa RA; Morales Sanfrutos J; Ritzefeld M; Tate EW
Mol Cell Proteomics; 2019 Jan; 18(1):115-126. PubMed ID: 30341083
[No Abstract] [Full Text] [Related]
5. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
6. N-Myristoylation as a Drug Target in Malaria: Exploring the Role of N-Myristoyltransferase Substrates in the Inhibitor Mode of Action.
Schlott AC; Holder AA; Tate EW
ACS Infect Dis; 2018 Apr; 4(4):449-457. PubMed ID: 29363940
[TBL] [Abstract][Full Text] [Related]
7. Validation and Invalidation of Chemical Probes for the Human N-myristoyltransferases.
Kallemeijn WW; Lueg GA; Faronato M; Hadavizadeh K; Goya Grocin A; Song OR; Howell M; Calado DP; Tate EW
Cell Chem Biol; 2019 Jun; 26(6):892-900.e4. PubMed ID: 31006618
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the discovery of N-myristoyltransferase inhibitors.
Zhao C; Ma S
ChemMedChem; 2014 Nov; 9(11):2425-37. PubMed ID: 25125080
[TBL] [Abstract][Full Text] [Related]
9. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.
Sikorski JA; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Nagarajan S; Mehta PP; Wade AC; Kishore NS; Bryant ML; Getman DP; McWherter CA; Gordon JI
Biopolymers; 1997; 43(1):43-71. PubMed ID: 9174411
[TBL] [Abstract][Full Text] [Related]
10. Targeting N-myristoylation for therapy of B-cell lymphomas.
Beauchamp E; Yap MC; Iyer A; Perinpanayagam MA; Gamma JM; Vincent KM; Lakshmanan M; Raju A; Tergaonkar V; Tan SY; Lim ST; Dong WF; Postovit LM; Read KD; Gray DW; Wyatt PG; Mackey JR; Berthiaume LG
Nat Commun; 2020 Oct; 11(1):5348. PubMed ID: 33093447
[TBL] [Abstract][Full Text] [Related]
11. A novel inhibitor protein of N-myristoyltransferase from Escherichia coli.
Gowda S; Shrivastav A; Selvakumar P; Dimmock JR; Sharma RK
Biochem Biophys Res Commun; 2004 Feb; 314(4):984-7. PubMed ID: 14751229
[TBL] [Abstract][Full Text] [Related]
12. Mammalian myristoyl CoA: protein N-myristoyltransferase.
Raju RV; Magnuson BA; Sharma RK
Mol Cell Biochem; 1995; 149-150():191-202. PubMed ID: 8569729
[TBL] [Abstract][Full Text] [Related]
13. Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria.
Duronio RJ; Jackson-Machelski E; Heuckeroth RO; Olins PO; Devine CS; Yonemoto W; Slice LW; Taylor SS; Gordon JI
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1506-10. PubMed ID: 2406721
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibitor of N-myristoylation: a novel molecular target for cancer.
Shrivastav A; Pasha MK; Selvakumar P; Gowda S; Olson DJ; Ross AR; Dimmock JR; Sharma RK
Cancer Res; 2003 Nov; 63(22):7975-8. PubMed ID: 14633729
[TBL] [Abstract][Full Text] [Related]
15. Genetic and biochemical studies establish that the fungicidal effect of a fully depeptidized inhibitor of Cryptococcus neoformans myristoyl-CoA:protein N-myristoyltransferase (Nmt) is Nmt-dependent.
Lodge JK; Jackson-Machelski E; Higgins M; McWherter CA; Sikorski JA; Devadas B; Gordon JI
J Biol Chem; 1998 May; 273(20):12482-91. PubMed ID: 9575206
[TBL] [Abstract][Full Text] [Related]
16. Expression of methionine aminopeptidase 2, N-myristoyltransferase, and N-myristoyltransferase inhibitor protein 71 in HT29.
Selvakumar P; Lakshmikuttyamma A; Lawman Z; Bonham K; Dimmock JR; Sharma RK
Biochem Biophys Res Commun; 2004 Sep; 322(3):1012-7. PubMed ID: 15336565
[TBL] [Abstract][Full Text] [Related]
17. N-Myristoyltransferase as a Glycine and Lysine Myristoyltransferase in Cancer, Immunity, and Infections.
Kosciuk T; Lin H
ACS Chem Biol; 2020 Jul; 15(7):1747-1758. PubMed ID: 32453941
[TBL] [Abstract][Full Text] [Related]
18. Regulation of N-myristoyltransferase by novel inhibitor proteins.
Shrivastav A; Selvakumar P; Bajaj G; Lu Y; Dimmock JR; Sharma RK
Cell Biochem Biophys; 2005; 43(1):189-202. PubMed ID: 16043893
[TBL] [Abstract][Full Text] [Related]
19. Purvalanol induces endoplasmic reticulum stress-mediated apoptosis and autophagy in a time-dependent manner in HCT116 colon cancer cells.
Coker-Gürkan A; Arisan ED; Obakan P; Akalın K; Özbey U; Palavan-Unsal N
Oncol Rep; 2015 Jun; 33(6):2761-70. PubMed ID: 25901510
[TBL] [Abstract][Full Text] [Related]
20. Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-based inhibitors of human N-myristoyltransferase-1.
French KJ; Zhuang Y; Schrecengost RS; Copper JE; Xia Z; Smith CD
J Pharmacol Exp Ther; 2004 Apr; 309(1):340-7. PubMed ID: 14724220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
